Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug

(American Friends of Tel Aviv University) US drug company obtains worldwide rights for an antibody fragment developed by Tel Aviv University that may have an advantage in treating cancer patients

source : www.eurekalert.org

Related News:

• Mainstream media slants cancer articles toward unrealistically positive outcomes
• Dense Bones Linked To Raised Risk For Prostate Cancer
• New Surgery Without Incisions Shows Promise For Prostate Cancer Treatment
• Socially active environment can cause cancer tumors to shrink and even disappear
• Blueberries May Boost Breast Cancer Defense
• Proposed Lowering Of PSA Threshold For Biopsy Could Result In Increased Overdiagnosis And Overtreatment Of Prostate Cancer, Study
• Association Of Body Mass Index With Prostate Cancer Biochemical Failure
• Starve A Cancer
• Circulating Aberrant Cells Increase As Non-Small Cell Lung Cancer Progresses
• Pool chemicals linked to disease

Details :
Submited at Wednesday, December 2nd, 2009 at 1:00 pm on Cancer and Oncology by ethan
Comment RSS 2.0 - leave a comment - trackback